�the kind of review being proposed does not, at least initially, appear to bring anything new or needed to is already a robust system of oversight,� mogulof said in the statement.
.
.
"we had (borrelia miyamotoi) as the new disease for the physicians to be aware of", told rusk.
.
. 
.
.